2025 FIRST-HALF BUSINESS FULL-YEAR REVENUES EXPECTED TO EXCEED €40M Bezons, July 23, 2025 - 8:00am - RIBER, the global leader in Molecular Beam Epitaxy (MBE) equipment for the semiconductor industry, reports its revenues for the first half of 2025. Business developments At June 30 (€m)20252024ChangeSystems7.89.4-17%Services and accessories3.04.3-31%Total half-year revenues 10.713.7-22% ...

Core Insights - RIBER has signed a three-year partnership with the Novo Nordisk Foundation Quantum Computing Programme (NQCP) to advance the ROSIE platform, aimed at enhancing silicon fab production lines [1][2][6] - The partnership includes the sale of the first ROSIE unit to NQCP, scheduled for delivery in the second half of 2025, which will be integrated into a pilot line for photonic technologies [3][6] - ROSIE is designed for oxide growth on 300 mm wafers and is compliant with SEMI standards, targeting strategic markets such as ultra-fast optical communications, optical computing, and photonic quantum technologies [2][8] Company and Industry Developments - The ROSIE platform, developed since 2021, represents RIBER's commitment to innovation in the semiconductor industry, supported by the Île-de-France Region and Bpifrance under the France 2030 investment plan [4] - The collaboration with NQCP is seen as a strategic move to accelerate the development of innovative processes in integrated silicon photonics, addressing market demands for performance, miniaturization, and energy efficiency [6][7] - RIBER aims to position itself as a key player in the European ecosystem for applied photonics research, showcasing the potential of French technology in the global market [6][7]